Yahoo!   My Yahoo!   Mail  
Search   
Sign In
New User? Sign Up
Home > Investing > TLCR > Summary

More on TLCR

Talecris Biotherapeutics Holdings Corp.
(TLCR)

22.50USD   Down 0.05 (0.22%)   
At 2:30AM IST
 Talecris Biotherapeutics Holdings Corp. (NasdaqNM:TLCR) Delayed quote data 
[Chart]
1d  5d  3m  6m 
Last Trade: 22.50USD
Trade Time:2:30AM IST
Change:Down 0.05 (0.22%) 
Prev Close:22.55
Open:22.50
Bid:21.82 x 100
Ask:N/A
1y Target Est:26.33
Day's Range:22.21 - 22.75
52wk Range:18.01 - 24.41
Volume:97,019
Avg Vol (3m):516,910
Market Cap:2.70B
P/E (ttm):11.90
EPS (ttm):1.89
Div & Yield:N/A (N/A%)
Add TLCR to Portfolio   Download Data

HEADLINES

 
•Talecris Biotherapeutics Receives Orphan Drug Designation for Aerosolized Alpha1-Proteinase Inhibitor to Treat Alpha1-Antitrypsin Deficiency - Business Wire  - Fri, Feb 5
•A Drugless Drugmaker IPO! - Motley Fool  - Fri, Feb 5
•Stephen Simpson Of Northland Securities Picks 4 Health Care Stock Winners For 2010 - Wall Street Transcript  - Thu, Jan 28
•HiSeq 2000 Genomics System Begins New Generation Of Innovation In DNA Sequencing Sector Of Biotech And Medical Diagnostics Industry - Wall Street Transcript  - Mon, Jan 25
•After A Sluggish Year, VCs Eye Improvement - Investor's Business Daily  - Sat, Jan 9
•Talecris Biotherapeutics to Present at the 28th Annual J.P. Morgan Healthcare Conference - Business Wire  - Sat, Jan 9
•PhRMA adds 7 biotech companies to its membership - AP  - Sat, Jan 9
•Talecris Biotherapeutics Appoints Drayton Virkler as Senior Director, Investor Relations - Business Wire  - Fri, Jan 8
•Coverage initiated on Talecris Biotherapeutics by BWS Financial - Briefing.com  - Tue, Jan 5
•TALECRIS BIOTHERAPEUTICS HOLDINGS CORP. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Stat - EDGAR Online  - Fri, Dec 18
» More Headlines for TLCR...

ANALYST

 
EPS Est (next year) (Dec-09) :1.36
EPS Est (in 2 years) (Dec-10) :1.54
Avg Rec (current)*:2.0
PEG Ratio:1.17
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
» Analyst Opinion» Estimates

BUSINESS SUMMARY

 
Talecris Biotherapeutics Holdings Corp., a biotherapeutic and biopharmaceutical company, engages in the production and marketing of plasma-derived protein therapies worldwide.

» Full Company Profile